Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Colorectal Neoplasms

  Free Subscription


1 Ann Oncol
3 Ann Surg
5 Ann Surg Oncol
2 BMC Gastroenterol
1 Br J Cancer
2 Br J Surg
1 Eur J Cancer
1 Gastrointest Endosc
1 Int J Cancer
5 Int J Colorectal Dis
4 J Surg Oncol
1 Lancet Infect Dis
1 N Engl J Med
1 Oncogene
1 Oncology
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Oncol

  1. MAURI G, Arena S, Siena S, Bardelli A, et al
    The DNA Damage Response pathway as a land of therapeutic opportunities for colorectal cancer.
    Ann Oncol. 2020 Jun 5. pii: S0923-7534(20)39869.
    PubMed         Abstract available

    Ann Surg

  2. ZHANG QX, Xu BB, Xue Z
    Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2020 Jun 4. doi: 10.1097/SLA.0000000000003856.

  3. AZOULAY D, Lim C
    Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": Shaking the Coconut Tree.
    Ann Surg. 2020;271:e122-e124.

  4. DUELAND S, Line PD
    Response to the Comment on"Survival Following Liver Transplantation for Patients With Non-resectable Liver Only Colorectal Metastases": What if those Lesions Are Gone?
    Ann Surg. 2020;271:e124.

    Ann Surg Oncol

  5. ZAIDI MY, Lee RM, Gamboa AC, Speegle S, et al
    Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.
    Ann Surg Oncol. 2020;27:156-164.
    PubMed         Abstract available

  6. ELLIS RJ, Schlick CJR, Yang AD, Barber EL, et al
    Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States.
    Ann Surg Oncol. 2020;27:214-221.
    PubMed         Abstract available

  7. GAMBOA AC, Zaidi MY, Lee RM, Speegle S, et al
    Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative.
    Ann Surg Oncol. 2020;27:134-146.
    PubMed         Abstract available

  8. NARAYAN RR, Harris JW, Chou JF, Gonen M, et al
    Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2020;27:188-195.
    PubMed         Abstract available

  9. GRAF W, Cashin PH, Ghanipour L, Enblad M, et al
    Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC.
    Ann Surg Oncol. 2020;27:293-300.
    PubMed         Abstract available

    BMC Gastroenterol

  10. YANG R, Chen Y, Chen X
    Value of routine test for identifying colorectal cancer from patients with nonalcoholic fatty liver disease.
    BMC Gastroenterol. 2020;20:180.
    PubMed         Abstract available

  11. LIAN H, Wang A, Shen Y, Wang Q, et al
    Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
    BMC Gastroenterol. 2020;20:171.
    PubMed         Abstract available

    Br J Cancer

  12. PERNOT S, Pellerin O, Artru P, Monterymard C, et al
    Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
    Br J Cancer. 2020 Jun 8. pii: 10.1038/s41416-020-0917.
    PubMed         Abstract available

    Br J Surg

  13. D'SOUZA N, Abulafi M
    Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    Br J Surg. 2020;107:e204.

  14. LACY AM, De Lacy FB, Balibrea JM
    Considerations for transanal total mesorectal excision (TaTME) use during the COVID-19 pandemic.
    Br J Surg. 2020;107:e203.

    Eur J Cancer

  15. SAKAI D, Taniguchi H, Sugimoto N, Tamura T, et al
    Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G).
    Eur J Cancer. 2020;135:11-21.
    PubMed         Abstract available

    Gastrointest Endosc

  16. SILVIA P, Franco R, Carlo S, Roberta M, et al
    Linked-color imaging versus white-light colonoscopy in an organized colorectal cancer screening program.
    Gastrointest Endosc. 2020 Jun 2. pii: S0016-5107(20)34379.
    PubMed         Abstract available

    Int J Cancer

  17. VOS JR, Fakkert IE, Spruijt L, Willems RW, et al
    Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
    Int J Cancer. 2020 Jun 8. doi: 10.1002/ijc.33117.
    PubMed         Abstract available

    Int J Colorectal Dis

  18. AUBERT M, Mege D, Manceau G, Bridoux V, et al
    Impact of hospital volume on outcomes after emergency management of obstructive colon cancer: a nationwide study of 1957 patients.
    Int J Colorectal Dis. 2020 Jun 5. pii: 10.1007/s00384-020-03602.
    PubMed         Abstract available

  19. FOGELSTROM A, Hallen F, Pekkari K
    Computed tomography diagnosed first time diverticulitis and colorectal cancer.
    Int J Colorectal Dis. 2020 Jun 10. pii: 10.1007/s00384-020-03607.
    PubMed         Abstract available

  20. WANG LM, Hirano YM, Ishii TM, Kondo HK, et al
    The role of apical lymph node metastasis in right colon cancer.
    Int J Colorectal Dis. 2020 Jun 8. pii: 10.1007/s00384-020-03661.
    PubMed         Abstract available

  21. QU G, Sun C, Sharma M, Uy JP, et al
    Is antibiotics use really associated with increased risk of colorectal cancer? An updated systematic review and meta-analysis of observational studies.
    Int J Colorectal Dis. 2020 Jun 6. pii: 10.1007/s00384-020-03658.
    PubMed         Abstract available

  22. DEL VECCHIO BLANCO G, Calabrese E, Biancone L, Monteleone G, et al
    The impact of COVID-19 pandemic in the colorectal cancer prevention.
    Int J Colorectal Dis. 2020 Jun 4. pii: 10.1007/s00384-020-03635.
    PubMed         Abstract available

    J Surg Oncol

  23. STEIN MK, Williard FW, Xiu J, Tsao MW, et al
    Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.
    J Surg Oncol. 2020;121:1320-1328.
    PubMed         Abstract available

  24. BINGMER K, Ofshteyn A, Bliggenstorfer JT, Kethman W, et al
    Primary tumor location impacts survival in colorectal cancer patients after resection of liver metastases.
    J Surg Oncol. 2020 Jun 10. doi: 10.1002/jso.26061.
    PubMed         Abstract available

  25. YANG J, Chen Q, Jindou L, Cheng Y, et al
    The influence of anastomotic leakage for rectal cancer oncologic outcome: A systematic review and meta-analysis.
    J Surg Oncol. 2020;121:1283-1297.
    PubMed         Abstract available

  26. SROUJI R, Narayan R, Boerner T, Buisman F, et al
    Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.
    J Surg Oncol. 2020;121:1314-1319.
    PubMed         Abstract available

    Lancet Infect Dis

  27. LIN C, Slama J, Gonzalez P, Goodman MT, et al
    Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.
    Lancet Infect Dis. 2019 Jun 13. pii: S1473-3099(19)30164.
    PubMed         Abstract available

    N Engl J Med

  28. RANDALL G, Abrahams J
    Cutaneous Colon Cancer Metastases in a Surgical Scar.
    N Engl J Med. 2020;382:e90.


  29. FONG W, Li Q, Yu J
    Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Oncogene. 2020 Jun 8. pii: 10.1038/s41388-020-1341.
    PubMed         Abstract available


  30. CHAN LF, Sadahiro S, Suzuki T, Okada K, et al
    Tissue-Infiltrating Lymphocytes as a Predictive Factor for Recurrence in Patients with Curatively Resected Colon Cancer: A Propensity Score Matching Analysis.
    Oncology. 2020 Jun 11:1-9. doi: 10.1159/000506706.
    PubMed         Abstract available

    PLoS One

  31. OGATA M, Kotaka M, Ogata T, Hatachi Y, et al
    Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
    PLoS One. 2020;15:e0234314.
    PubMed         Abstract available

  32. ASADOLLAHI P, Ghanavati R, Rohani M, Razavi S, et al
    Correction: Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
    PLoS One. 2020;15:e0234777.
    PubMed         Abstract available

  33. HUANG CS, Chen CY, Huang LK, Wang WS, et al
    Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke.
    PLoS One. 2020;15:e0233687.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.